European Journal of Nutrition

, Volume 52, Issue 1, pp 169–178 | Cite as

Serum taurine and risk of coronary heart disease: a prospective, nested case–control study

  • Oktawia P. Wójcik
  • Karen L. Koenig
  • Anne Zeleniuch-Jacquotte
  • Camille Pearte
  • Max Costa
  • Yu ChenEmail author
Original Contribution



Taurine (2-aminoethanesulfonic acid), a molecule obtained from diet, is involved in bile acid conjugation, blood pressure regulation, anti-oxidation and anti-inflammation. We performed the first prospective study of taurine and CHD risk.


We conducted a case–control study nested in the New York University Women’s Health Study to evaluate the association between circulating taurine levels and risk of coronary heart disease (CHD). Taurine was measured in two yearly pre-diagnostic serum samples of 223 CHD cases and 223 matched controls and averaged for a more reliable measurement of long-term taurine levels.


Mean serum taurine was positively related to age and dietary intake of poultry, niacin, vitamin B1, fiber and iron, and negatively related to dietary intake of saturated fat (all p values ≤0.05). There was no statistically significant association between serum taurine levels and the risk of CHD in the overall study population. The adjusted ORs for CHD in increasing taurine tertiles were 1.0 (reference), 0.85 (95% CI, 0.51–1.40) and 0.66 (0.39–1.13; p for trend = 0.14). There was a significant inverse association between serum taurine and CHD risk among women with high total serum cholesterol (>250 mg/dL) (adjusted OR = 0.39 (0.19–0.83) for the third versus first tertile; p for trend = 0.02) but not among those with low total serum cholesterol (p for interaction = 0.01). The data suggest a possible inverse association of serum taurine with diabetes and hypertension risk.


The findings suggest that high levels of taurine may be protective against CHD among individuals with high serum cholesterol levels.


Taurine Serum Coronary heart disease NYUWHS Epidemiology 



This research was supported by U.S. grants: NIH grants ES000260, CA16087, CA098661 and American Heart Association grant 0835569D. The authors thank Mr. Alan Bowers and Mrs. Yelena Afanasyeva for their involvement in the study.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    AHA (2009) 2009 Update at-a-glance. American Heart Association, Dallas, pp 1–36Google Scholar
  2. 2.
    Mente A, de Koning L, Shannon HS, Anand SS (2009) A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169:659–669CrossRefGoogle Scholar
  3. 3.
    Visioli F, Hagen TM (2007) Nutritional strategies for healthy cardiovascular aging: focus on micronutrients. Pharmacol Res 55:199–206CrossRefGoogle Scholar
  4. 4.
    Yamori Y, Nara Y, Ikeda K, Mizushima S (1996) Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition? Adv Exp Med Biol 403:623–629Google Scholar
  5. 5.
    Mizushima S, Moriguchi EH, Ishikawa P, Hekman P, Nara Y et al (1997) Fish intake and cardiovascular risk among middle-aged Japanese in Japan and Brazil. J Cardiovasc Risk 4:191–199CrossRefGoogle Scholar
  6. 6.
    Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163Google Scholar
  7. 7.
    Yamori Y, Liu L, Mizushima S, Ikeda K, Nara Y (2006) Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. J Hypertens 24:1499–1505CrossRefGoogle Scholar
  8. 8.
    Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S et al (2001) Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res 24:453–457CrossRefGoogle Scholar
  9. 9.
    Greenland S, Robins J (1994) Invited commentary: ecologic studies—biases, misconceptions, and counterexamples. Am J Epidemiol 139:747–760Google Scholar
  10. 10.
    Mizushima S, Nara Y, Sawamura M, Yamori Y (1996) Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 403:615–622Google Scholar
  11. 11.
    Zhang M, Bi LF, Fang JH, Su XL, Da GL et al (2004) Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 26:267–271Google Scholar
  12. 12.
    Liu L, Liu L, Ding J, Huang Z, He B et al (2001) Ethnic and environmental differences in various markers of dietary intake and blood pressure among Chinese Han and three other minority peoples of China: results from the WHO cardiovascular diseases and alimentary comparison (CARDIAC) study. Hepertens Res 24:315–322CrossRefGoogle Scholar
  13. 13.
    Fujita T, Katsuyuki A, Noda H, Yasushi I, Sato Y (1987) Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75:525–532CrossRefGoogle Scholar
  14. 14.
    Wójcik O, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y (2010) The potential protective effects of taurine on coronary heart disease. Atherosclerosis 208:19–25CrossRefGoogle Scholar
  15. 15.
    Toniolo PG, Pasternack BS, Shore RE, Sonnenschein E, Koenig KL et al (1991) Endogenous hormones and breast cancer: a prospective cohort study. Breast Cancer Res Treat 18:S23–S26CrossRefGoogle Scholar
  16. 16.
    Block G, Hartman AM (1989) Issues in reproducibility and validity of dietary studies. Am J Clin Nutr 50:1133–1138Google Scholar
  17. 17.
    Riboli E, Toniolo P, Kaaks R, Shore RE, Casagrande C et al (1997) Reproducibility of a food frequency questionnaire used in the New York University Women’s Health Study: effect of self-selection by study subjects. Eur J Clin Nutr 51:437–442CrossRefGoogle Scholar
  18. 18.
    Rose GA, Blackburn H, Gillum RF, Prineas RJ (1982) Cardiovascular survey methods. World Health Organization, GenevaGoogle Scholar
  19. 19.
    Wójcik O, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y (2010) Reproducibility of HPLC taurine measurements in frozen serum of healthy postmenopausal women. Br J Nutr 104:629–632CrossRefGoogle Scholar
  20. 20.
    Al-Delaimy WK, Natarajan L, Sun X, Rock CL, Pierce JP, Women’s Healthy Eating and Living (WHEL) Study Group (2008) Reliability of plasma carotenoid biomarkers and its relation to study power. Epidemiology 19:338–344CrossRefGoogle Scholar
  21. 21.
    Hunter D (1998) Biochemical indicators of dietary intake. In: Willett W (ed) Nutritional epidemiology, 2nd edn. Oxford University Press, New York, pp 174–243Google Scholar
  22. 22.
    Tcherkas YV, Kartsova LA, Krasnova IN (2001) Analysis of amino acids in human serum by isocratic reversed-phase high-performance lipid chromatography with electrochemical detection. J Chromatogr A 913:303–308CrossRefGoogle Scholar
  23. 23.
    McNamara JR, Huang C, Massov T, Leary ET, Warnick GR et al (1994) Modification of the dextran-Mg2 + high-density lipoprotein cholesterol precipitation method for use with previously frozen plasma. Clin Chem 40:233–239Google Scholar
  24. 24.
    Kimberly MM, Leary ET, Cole TG, Waymack PP (1999) Selection, validation, standardization, and performance of a designated comparison method for HDL-cholesterol for use in the cholesterol reference method laboratory network. Clin Chem 45:1803–1812Google Scholar
  25. 25.
    Breslow N, Day NE (1980) Conditional logistic regression for matched sets. In: Davis W (ed) Statistical methods in cancer research vol 1 the analysis of case-control studies. IARC, Lyon, pp 248–279Google Scholar
  26. 26.
    Ito M (2004) The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin. Ann Pharmacother 38:277–285CrossRefGoogle Scholar
  27. 27.
    Woodside J, McKinley MC, Young IS (2008) Saturated and trans fatty acids and coronary heart disease. Curr Atheroscler Rep 10:460–466CrossRefGoogle Scholar
  28. 28.
    Hu FB, Willett WC (2002) Optimal diets for prevention of coronary heart disease. JAMA 288:2569–2578CrossRefGoogle Scholar
  29. 29.
    Renaud S, Lanzmann-Petithoty D (2001) Coronary heart disease: dietary links and pathogenesis. Public Health Nutr 4:459–474CrossRefGoogle Scholar
  30. 30.
    Meyers D (1996) The iron hypothesis—does iron cause atherosclerosis? Clin Cardiol 19:925–929CrossRefGoogle Scholar
  31. 31.
    Willett WC (1998) Nutritional epidemiology. Oxford University Press, New York, p 514CrossRefGoogle Scholar
  32. 32.
    Finnegan D (2003) The health effects of stimulant drinks. Br Nutr Found Nutr Bull 28:147–155CrossRefGoogle Scholar
  33. 33.
    Schuller-Levis GB, Park E (2003) Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:195–202CrossRefGoogle Scholar
  34. 34.
    Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB et al (2003) Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the health, aging, and body composition study. Arterioscler Thromb Vasc Biol 23:1444–1448CrossRefGoogle Scholar
  35. 35.
    Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB (2006) Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among US men and women? J Am Coll Cardiol 48:973–979CrossRefGoogle Scholar
  36. 36.
    Tan B, Jiang D, Huang H, Jia J, Jiang JL, Hu C, Li Y (2007) Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Vasc Pharmacol 46:338–345CrossRefGoogle Scholar
  37. 37.
    Matsushima Y, Sekine T, Kondo T, Kameo K, Tachibana M, Murakami S (2003) Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidaemic mice. Clin Exp Pharmacol Physiol 30:295–299CrossRefGoogle Scholar
  38. 38.
    Laidlaw SA, Grosvenor M, Kopple JD (1990) The taurine content of common foodstuffs. J Parenter Enteral Nutr 14:183–188CrossRefGoogle Scholar
  39. 39.
    Pasantes-Morales H, Quesada O, Alcocer L, Sánchez Olea R (1989) Taurine content in foods. Nutr Rep Int 40:793–801Google Scholar
  40. 40.
    Lourenço R, Camilo ME (2002) Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp 17:262–270Google Scholar
  41. 41.
    Kim ES, Kim KJ, Yim MH, Joeng Y, Ko YS, Watanabe T, Nakatsuka H, Nakatsuka S, Matsuda-Inoguchi N, Shimbo S, Ikeda M (2003) Dietary taurine intake and serum taurine levels of women on Jeju Island. Adv Exp Med Biol 526:277–283Google Scholar
  42. 42.
    Elizarova E, Nedosugova LV (1996) First experiments in taurine administration for diabetes mellitus—the effect of erythrocyte membranes. Adv Exp Med Biol 403:583–588Google Scholar
  43. 43.
    Koenig K, Toniolo P, Bruning P, Bonfrer J, Shore R, Pasternack B (1993) Reliability of serum prolactin measurements in women. Cancer Epidemiol Biomarker Prev 2:411–414Google Scholar
  44. 44.
    Martin L, Leff M, Calonge N, Garrett C, Nelson DE (2000) Validation of self-reported chronic conditions and health services in managed care populations. Am J Prev Med 18:215–218CrossRefGoogle Scholar
  45. 45.
    Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57:1093–1103CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Oktawia P. Wójcik
    • 1
  • Karen L. Koenig
    • 1
  • Anne Zeleniuch-Jacquotte
    • 1
    • 2
  • Camille Pearte
    • 3
  • Max Costa
    • 1
    • 2
    • 4
  • Yu Chen
    • 2
    • 5
    Email author
  1. 1.Department of Environmental MedicineNew York University School of MedicineNew YorkUSA
  2. 2.New York University Cancer Institute, New York University School of MedicineNew YorkUSA
  3. 3.Department of Medicine, Division of CardiologyNew York University School of MedicineNew YorkUSA
  4. 4.Department of PharmacologyNew York University School of MedicineNew YorkUSA
  5. 5.Department of Environmental MedicineNew York University School of MedicineNew YorkUSA

Personalised recommendations